Literature DB >> 10486579

beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria.

L Canevari1, J B Clark, T E Bates.   

Abstract

Defects in mitochondrial oxidative metabolism, in particular decreased activity of cytochrome c oxidase, have been demonstrated in Alzheimer's disease, and after the expression of the amyloid precursor protein (APP) in cultured cells, suggesting that mitochondria might be involved in beta-amyloid toxicity. Recent evidence suggests that the proteolysis of APP to generate beta-amyloid is at least in part intracellular, preceding the deposition of extracellular fibrils. We have therefore investigated the effect of incubation of isolated rat brain mitochondria with the beta-amyloid fragment 25-35 (100 microM) on the activities of the mitochondrial respiratory chain complexes I, II-III, IV (cytochrome c oxidase) and citrate synthase. The peptide caused a rapid, dose-dependent decrease in the activity of complex IV, white it had no effect on the activities on any of the other enzymes tested. The reverse sequence peptide (35-25) had no effect on any of the activities measured. We conclude that inhibition of mitochondrial complex IV might be a contributing factor to the pathogenesis of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486579     DOI: 10.1016/s0014-5793(99)01028-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  63 in total

Review 1.  NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance.

Authors:  V Calabrese; T E Bates; A M Stella
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 2.  Neurodegeneration or neuroprotection: the pivotal role of astrocytes.

Authors:  Simon J R Heales; Amanda A J Lam; Andrew J Duncan; John M Land
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

Review 3.  The Alzheimer's disease mitochondrial cascade hypothesis.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Mitochondrial FOXO3a is involved in amyloid β peptide-induced mitochondrial dysfunction.

Authors:  Chun Shi; Jianhua Zhu; Shuilong Leng; Dahong Long; Xiumei Luo
Journal:  J Bioenerg Biomembr       Date:  2016-01-19       Impact factor: 2.945

Review 5.  The neurodegenerative mitochondriopathies.

Authors:  Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 6.  Alzheimer's disease pathologic cascades: who comes first, what drives what.

Authors:  Russell H Swerdlow
Journal:  Neurotox Res       Date:  2011-09-13       Impact factor: 3.911

Review 7.  The role of mitochondria in neurodegenerative diseases.

Authors:  Massimiliano Filosto; Mauro Scarpelli; Maria Sofia Cotelli; Valentina Vielmi; Alice Todeschini; Valeria Gregorelli; Paola Tonin; Giuliano Tomelleri; Alessandro Padovani
Journal:  J Neurol       Date:  2011-05-22       Impact factor: 4.849

8.  Epoxyeicosatrienoic acids pretreatment improves amyloid β-induced mitochondrial dysfunction in cultured rat hippocampal astrocytes.

Authors:  Pallabi Sarkar; Ivan Zaja; Martin Bienengraeber; Kevin R Rarick; Maia Terashvili; Scott Canfield; John R Falck; David R Harder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

Review 9.  Mouse models of mitochondrial complex I dysfunction.

Authors:  Michael H Irwin; Kodeeswaran Parameshwaran; Carl A Pinkert
Journal:  Int J Biochem Cell Biol       Date:  2012-08-10       Impact factor: 5.085

Review 10.  Activation of PARP by oxidative stress induced by β-amyloid: implications for Alzheimer's disease.

Authors:  Rosella Abeti; Michael R Duchen
Journal:  Neurochem Res       Date:  2012-10-18       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.